South African COVID variant can ‘break through’ Pfizer vaccine, Israeli study says – ABC News

Article feature image

The coronavirus variant discovered in South Africa can “break through” the Pfizer COVID-19 vaccine to some extent, a real-world data study in Israel has found, though its prevalence in the country is low and the research has not been peer-reviewed.
Key points:

  • The study only had a small sample size of people infected with the South African variant
  • Pfizer and BioNTech have said their vaccine was around 91 per cent effective
  • Some previous studies have indicated that the Pfizer shot was less potent against…

Click here to view the original article.